These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 29673321)

  • 1. Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis.
    Yu R; Shi Q; Liu L; Chen L
    BMC Gastroenterol; 2018 Apr; 18(1):51. PubMed ID: 29673321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia Contributes to the Progression of Nonalcoholic Fatty Liver Disease- Related Fibrosis: A Meta-Analysis.
    Pan X; Han Y; Zou T; Zhu G; Xu K; Zheng J; Zheng M; Cheng X
    Dig Dis; 2018; 36(6):427-436. PubMed ID: 30048963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Cai C; Song X; Chen Y; Chen X; Yu C
    Hepatol Int; 2020 Jan; 14(1):115-126. PubMed ID: 31290072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
    Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
    Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
    Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD) Is Associated With Advanced Fibrosis.
    Harring M; Golabi P; Paik JM; Shah D; Racila A; Cable R; Srishord M; Younossi ZM
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2876-2888.e5. PubMed ID: 36848980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of sarcopenia with liver fibrosis and steatohepatitis in non-alcoholic fatty liver disease: protocol for a systematic review and meta-analysis.
    Wang Z; Li S; Wang K; Zhang M; Wu J; Liu D; Liang K
    BMJ Open; 2023 Feb; 13(2):e066181. PubMed ID: 36737085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.
    Jiang ZG; Tapper EB; Connelly MA; Pimentel CF; Feldbrügge L; Kim M; Krawczyk S; Afdhal N; Robson SC; Herman MA; Otvos JD; Mukamal KJ; Lai M
    Liver Int; 2016 Aug; 36(8):1213-20. PubMed ID: 26815314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis.
    Bhanji RA; Narayanan P; Allen AM; Malhi H; Watt KD
    Hepatology; 2017 Dec; 66(6):2055-2065. PubMed ID: 28777879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research advances in the relationship between nonalcoholic fatty fiver disease and sarcopenia].
    Yu R; Shi QW; Wang CF; Chen LD; Zhang LF
    Zhonghua Gan Zang Bing Za Zhi; 2019 Sep; 27(9):725-727. PubMed ID: 31594102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.
    Rich NE; Oji S; Mufti AR; Browning JD; Parikh ND; Odewole M; Mayo H; Singal AG
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):198-210.e2. PubMed ID: 28970148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis.
    Wijarnpreecha K; Panjawatanan P; Thongprayoon C; Jaruvongvanich V; Ungprasert P
    Saudi J Gastroenterol; 2018; 24(1):12-17. PubMed ID: 29451179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease.
    Yang BB; Chen YH; Zhang C; Shi CE; Hu KF; Zhou J; Xu DX; Chen X
    Endocrine; 2017 Feb; 55(2):582-590. PubMed ID: 27796814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between nonalcoholic steatohepatitis and high serum ferritin levels in type 2 diabetes mellitus.
    Wang T; He L; Wang S; Ma D
    Rev Assoc Med Bras (1992); 2024; 70(7):e20231405. PubMed ID: 39045927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease.
    Chun HS; Lee M; Lee HA; Oh SY; Baek HJ; Moon JW; Kim YJ; Lee J; Kim H; Kim HY; Yoo K; Kim TH; Kim SU
    Clin Gastroenterol Hepatol; 2023 Feb; 21(2):358-369.e12. PubMed ID: 34998993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic steatohepatitis and diabetes.
    Caballeria J; Caballeria L
    Endocrinol Nutr; 2016 Oct; 63(8):377-9. PubMed ID: 27423933
    [No Abstract]   [Full Text] [Related]  

  • 19. Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis.
    Kang SH; Yoon EL
    Gut Liver; 2023 Jan; 17(1):8-9. PubMed ID: 36636885
    [No Abstract]   [Full Text] [Related]  

  • 20. Subclinical Hypothyroidism and Low-Normal Thyroid Function Are Associated With Nonalcoholic Steatohepatitis and Fibrosis.
    Kim D; Kim W; Joo SK; Bae JM; Kim JH; Ahmed A
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):123-131.e1. PubMed ID: 28823829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.